✦ LIBER ✦

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates

✍ Scribed by Diane L. Bolton; Sampa Santra; Cindy Swett-Tapia; Jerome Custers; Kaimei Song; Harikrishnan Balachandran; Linh Mach; Hussein Naim; Pamela A. Kozlowski; Michelle Lifton; Jaap Goudsmit; Norman Letvin; Mario Roederer; Katarina Radošević

Book ID: 118503185
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 662 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.06.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing HIV-1-specific CD8+ T-cell in

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors

✍ Richard Hopkins; Anne Bridgeman; Charles Bourne; Alice Mbewe-Mvula; Jerald C. Sa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

Heterologous prime-boost strategy in non

Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use

✍ Iris Valdés; Lisset Hermida; Lázaro Gil; Laura Lazo; Jorge Castro; Jorge Martín; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Heterologous prime-boost vaccination wit

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

✍ I. Ramos; A. Alonso; J.M. Marcen; A. Peris; J.A. Castillo; M. Colmenares; V. Lar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 855 KB

Enhanced CD8 T cell immunogenicity and p

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes

✍ Sarah C Gilbert; Jörg Schneider; Carolyn M Hannan; Jiang Ting Hu; Magdalena Pleb 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Antibody responses to human rotavirus (H

Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM

✍ A. M. GONZÁLEZ; T. V. NGUYEN; M. S. P. AZEVEDO; K. JEONG; F. AGARIB; C. IOSEF; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB